Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. META
5. SPY
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients

Tiziana Life Sciences (TLSA) Prices 11M ADS Follow-Offering at $5.20/ADS

August 3, 2020 5:51 AM EDT

Tiziana Life Sciences plc (NASDAQ: TLSA) today announced it has entered into definitive agreements with investors for the purchase and sale of 11,009,615 of the Companys American Depositary Shares (ADSs) at a price of $5.20 per ADS pursuant to a registered direct offering (the "Offering"). Each ADS offered represents two ordinary shares of nominal value £0.03 each ("Ordinary Shares"), following the recent forward split of the ADSs which became effective on 31 July 2020. The... More